CAMP4 Therapeutics (NASDAQ: CAMP) net income
CAMP4 Therapeutics reported a net loss of $80.4m for fiscal 2025; in fiscal 2024 it reported a net loss of $51.8m. Earnings per share were −$2.65.
CAMP4 Therapeutics's best year of the last 3 was fiscal 2023. It reported a loss in 3 of those 3 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$80.4m | — | −2,298.5% | −$2.65 |
| 2024 | −$51.8m | — | −7,943.4% | −$11.04 |
| 2023 | −$49.3m | — | −14,083.1% | −$124.80 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
CAMP4 Therapeutics net income compared with its sector
By net income for its latest fiscal year, CAMP4 Therapeutics ranks 313th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of CAMP4 Therapeutics, −2,298.5%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 311th | X4 Pharmaceuticals | −$79.2m | −225.6% |
| 312th | Beam Therapeutics | −$80.0m | −57.2% |
| 313th | CAMP4 Therapeutics | −$80.4m | −2,298.5% |
| 314th | STAAR Surgical | −$80.4m | −33.6% |
| 315th | Bioage Labs | −$80.6m | −896.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of CAMP4 Therapeutics
- How much did CAMP4 Therapeutics earn in fiscal 2025?
- CAMP4 Therapeutics reported a net loss of $80.4m for fiscal 2025. In fiscal 2024 it reported a net loss of $51.8m.
- What are the earnings per share of CAMP4 Therapeutics?
- They were −$2.65 in fiscal 2025, compared with −$11.04 in fiscal 2024.
- Where does CAMP4 Therapeutics rank in its sector by net income?
- It ranks 313th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for CAMP4 Therapeutics come from?
- From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on CAMP4 Therapeutics: the CAMP4 Therapeutics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.